Cumberland Pharmaceuticals (CPIX) Non-Current Deferred Tax Liability (2011)

Cumberland Pharmaceuticals (CPIX) posted Non-Current Deferred Tax Liability of $645029.0 for Q4 2011.

Cumberland Pharmaceuticals (CPIX) Non-Current Deferred Tax Liability (2011) Analysis & Trends

Cumberland Pharmaceuticals has reported Non-Current Deferred Tax Liability for 1 years, with the latest figure at $645029.0 in Q4 2011.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $645029.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $645029.0 (changed N/A YoY) and the FY2011 annual result came in at $645029.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability was little changed at $645029.0 in Q4 2011 per CPIX's latest filing.
Over five years, Non-Current Deferred Tax Liability peaked at $645029.0 in Q4 2011 and troughed at $645029.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Cumberland Pharmaceuticals	114.68 Mn	110.82 Mn	-

Download Data

Date	Value
Dec 31, 2011	645,029.00
Dec 31, 2011	645,029.00